USA - NASDAQ:PIII - US7444132044 - Common Stock
The current stock price of PIII is 7.5101 USD. In the past month the price decreased by -10.29%. In the past year, price decreased by -57.12%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.45 | 99.46B | ||
| CI | THE CIGNA GROUP | 9.23 | 69.99B | ||
| LH | LABCORP HOLDINGS INC | 15.73 | 20.68B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.45 | 20.14B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 108.44 | 19.59B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.59B | ||
| HIMS | HIMS & HERS HEALTH INC | 69.49 | 8.95B | ||
| DVA | DAVITA INC | 13.33 | 8.80B | ||
| CHE | CHEMED CORP | 19.88 | 6.37B | ||
| RDNT | RADNET INC | 216.67 | 6.00B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 31.74 | 5.73B | ||
| OPCH | OPTION CARE HEALTH INC | 18.4 | 4.45B |
P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 360 full-time employees. The company went IPO on 2021-02-10. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
P3 HEALTH PARTNERS INC
2045 W Grand Ave Ste B, Pmb # 82152
Chicago ILLINOIS US
Employees: 360
Phone: 13128228897
P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 360 full-time employees. The company went IPO on 2021-02-10. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. The company has a network of more than 3,100 affiliated primary care providers across the country. Its local teams of healthcare professionals manage the care of thousands of patients in 27 counties across five states.
The current stock price of PIII is 7.5101 USD. The price decreased by -6.46% in the last trading session.
PIII does not pay a dividend.
PIII has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
PIII stock is listed on the Nasdaq exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PIII.
P3 HEALTH PARTNERS INC (PIII) has a market capitalization of 54.00M USD. This makes PIII a Micro Cap stock.
ChartMill assigns a technical rating of 2 / 10 to PIII. When comparing the yearly performance of all stocks, PIII is a bad performer in the overall market: 84.66% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to PIII. Both the profitability and financial health of PIII have multiple concerns.
Over the last trailing twelve months PIII reported a non-GAAP Earnings per Share(EPS) of -46.51. The EPS decreased by -57.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.95% | ||
| ROE | -328.33% | ||
| Debt/Equity | 2.3 |
10 analysts have analysed PIII and the average price target is 13.94 USD. This implies a price increase of 85.62% is expected in the next year compared to the current price of 7.5101.
For the next year, analysts expect an EPS growth of 49.92% and a revenue growth -5.4% for PIII